Top Markets
#1 Akedo Akedo +58.73%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +47.62%
#4 Velvet Velvet +38.36%
#5 Black Phoenix Black Phoenix +33.94%
#6 Cross Cross +27.05%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +17.76%
#8 QANplatform QANplatform +14.60%
#9 Perle Perle +14.17%
#10 Bitway Bitway +13.96%
Coin of the day
Akedo Akedo
Settings
Language
ENGLISH
Currency
USD
Theme
AIM ImmunoTech Inc. AIM ImmunoTech Inc.

AIM ImmunoTech Inc.

AIM
Rank in Stocks #38740
AIM ImmunoTech Inc., an immuno-pharmaceutical company based in Ocala, Florida,... AIM ImmunoTech Inc., an immuno-pharmaceutical company based in Ocala, Florida, focuses on discovering and advancing treatments for a diverse array of cancers, viral infections, and immune system disorders across the United States. Its primary drug offerings include Ampligen (rintatolimod), a large macromolecular double-stranded ribonucleic acid compound developed for chronic fatigue syndrome, and Alferon N Injection (Interferon alfa), a purified, naturally derived, multi-species alpha interferon prescribed for genital warts. Furthermore, Ampligen is currently undergoing investigation for its potential application in treating pancreatic, renal cell, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, and prostate cancers, as well as myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. The company, originally incorporated in 1966, was formerly known as Hemispherx Biopharma, Inc. until its name change in August 2019.
Share Price
$0.2432
Market Cap
$827.74K
Change (1 day)
-5.85%
Change (1 year)
-89.95%
Country
US
Trade AIM ImmunoTech Inc. (AIM)

Category

Healthcare
P/B ratio for AIM ImmunoTech Inc. (AIM)
P/B ratio as of 2026 TTM: 0
According to AIM ImmunoTech Inc. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for AIM ImmunoTech Inc. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.2613 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.3483 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.634 -
BE